Interview with Harry Flore, CEO, HAL Allergy Group
Our meetings frequently bring us here to the Leiden Bio Science Park, but more often than not, to meet with younger, up-and-coming companies. HAL Allergy, meanwhile, has a rich and…
Chiesi is an Italian pharmaceutical family company founded in 1935 by Giacomo Chiesi. Since 2007, Chiesi has been active in the Netherlands. Headquartered in Parma, Italy, the company has a presence in 66 countries. Chiesi provides innovative pharmaceutical solutions and medications, and contributes to the improvement of diagnosis and treatment through the Knowledge Chiesi College. In addition, Chiesi promotes scientific research and talent from the Chiesi Foundation. Chiesi is active on five continents and has four research centers and three manufacturing facilities, and employs over 4000 people. The company had 2014 worldwide sales of over 1.4 billion euros and a turnover of 33 million euros.
Chiesi adopts a personal and honest approach in an organization where employees are given the opportunity to develop their entrepreneurial spirit. We are an organization which strives to develop therapies for patients. Chiesi Netherlands comprises two different departments, General Care and Special Care. General Care engages in drug treatments in the field of asthma and COPD. Special Care focuses on cystic fibrosis, respiratory distress syndrome in premature infants (neonatology), hyaline membrane disease, kidney and liver transplants, stem cell therapy and genetic fat metabolism disease LPL deficiency. With 53 employees in the country, Chiesi is a modest but growing force in the Netherlands.
Contact
Chiesi Pharmaceuticals B.V.
Lange Kleiweg 52 J, 2288 GK Rijswijk
Postbus 1147, 2280 CC Rijswijk
Our meetings frequently bring us here to the Leiden Bio Science Park, but more often than not, to meet with younger, up-and-coming companies. HAL Allergy, meanwhile, has a rich and…
You are still relatively new to the Netherlands having been here for one year. This must be a very insightful experience abroad. What were your initial expectations and first impressions…
You began as managing director of this Dutch affiliate close to one year ago. What was the trajectory that led you to this position and what were your initial impressions…
Since its founding Galapagos has operated with a hybrid business model which has combined its internal discoveries with service activities. This model has worked quite well as it has now…
As much as this report is about business trends and insights, we also like to portray the personalities of the industry in the markets that we cover. What has been…
Shire has many offices in America, Europe, as well as in Singapore, in Japan and in Australia. The group has a vast global network and a strong presence in these…
Promega is a truly global company with a vast international presence. What would you say is the strategic importance that the Benelux affiliate has assumed within Promega’s global network? Promega…
See our Cookie Privacy Policy Here
